Journal list menu
Export Citations
Download PDFs
Issue Information
Editorial
Open Access
oa
Shear wave elastography to evaluate hepatic damage in heart failure
- Pages: 1735-1737
- First Published: 02 May 2021
Review
Open Access
oa
Metabolomics and cardiovascular imaging: a combined approach for cardiovascular ageing
- Pages: 1738-1750
- First Published: 30 March 2021
Original Research Articles
Open Access
oa
Efficacy of shear wave elastography for assessment of liver function in patients with heart failure
- Pages: 1751-1758
- First Published: 24 March 2021
Open Access
oa
One year prognostic value of B-lines in dyspnoeic patients
- Pages: 1759-1766
- First Published: 11 March 2021
Open Access
oa
Prognostic impact of hospital-acquired disability in elderly patients with heart failure
- Pages: 1767-1774
- First Published: 10 April 2021
Open Access
oa
Sex differences in patients with cardiogenic shock
- Pages: 1775-1783
- First Published: 24 March 2021
Open Access
oa
Sex differences in congestive markers in patients hospitalized for acute heart failure
- Pages: 1784-1795
- First Published: 11 March 2021
Open Access
oa
One year improvement of exercise capacity in patients with mechanical circulatory support as bridge to transplantation
- Pages: 1796-1805
- First Published: 12 March 2021
Open Access
oa
Effects of different exercise modalities on cardiac dysfunction in heart failure with preserved ejection fraction
- Pages: 1806-1818
- First Published: 25 March 2021
Open Access
oa
Differential effect of malnutrition between patients hospitalized with new-onset heart failure and worsening of chronic heart failure
- Pages: 1819-1826
- First Published: 02 March 2021
Open Access
oa
Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score
- Pages: 1827-1839
- First Published: 03 March 2021
Open Access
oa
Longitudinal profiling of circulating miRNA during cardiac allograft rejection: a proof-of-concept study
- Pages: 1840-1849
- First Published: 13 March 2021
Open Access
oa
The potential role of plasma miR-155 and miR-206 as circulatory biomarkers in inflammatory cardiomyopathy
- Pages: 1850-1860
- First Published: 08 April 2021
Open Access
oa
Evaluation of phosphodiesterase 9A as a novel biomarker in heart failure with preserved ejection fraction
- Pages: 1861-1872
- First Published: 30 March 2021
Open Access
oa
Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality
- Pages: 1873-1884
- First Published: 28 March 2021
Open Access
oa
Effect of Carillon Mitral Contour System on patient-reported outcomes in functional mitral regurgitation: an individual participant data meta-analysis
- Pages: 1885-1891
- First Published: 30 March 2021
Open Access
oa
Hypertrophic remodelling of retinal arterioles in patients with congestive heart failure
- Pages: 1892-1900
- First Published: 30 March 2021
Open Access
oa
Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion
- Pages: 1901-1914
- First Published: 03 March 2021
Open Access
oa
Resource utilization and costs among patients with heart failure with reduced ejection fraction following a worsening heart failure event
- Pages: 1915-1923
- First Published: 10 March 2021
Open Access
oa
Prognostic impact of acute pulmonary triggers in patients with takotsubo syndrome: new insights from the International Takotsubo Registry
- Pages: 1924-1932
- First Published: 13 March 2021
Open Access
oa
Mineralocorticoid receptor blockade with finerenone improves heart function and exercise capacity in ovariectomized mice
- Pages: 1933-1943
- First Published: 20 March 2021
Open Access
oa
Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure
- Pages: 1944-1953
- First Published: 04 March 2021
Open Access
oa
Smoking and heart failure: a Mendelian randomization and mediation analysis
- Pages: 1954-1965
- First Published: 03 March 2021
Open Access
oa
Fat-1 transgenic mice rich in endogenous omega-3 fatty acids are protected from lipopolysaccharide-induced cardiac dysfunction
- Pages: 1966-1978
- First Published: 04 March 2021
Open Access
oa
Prostaglandin E2 induced cardiac hypertrophy through EP2 receptor-dependent activation of β-catenin in 5/6 nephrectomy rats
- Pages: 1979-1989
- First Published: 06 April 2021
Open Access
oa
Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement
- Pages: 1990-2001
- First Published: 05 March 2021
Open Access
oa
Determinants of maximal oxygen uptake in patients with heart failure
- Pages: 2002-2008
- First Published: 27 March 2021
Open Access
oa
Incidence and clinical/laboratory correlates of early hypotension in takotsubo syndrome
- Pages: 2009-2015
- First Published: 24 March 2021
Open Access
oa
Neprilysin inhibition does not alter dynamic of proenkephalin-A 119-159 and pro-substance P in heart failure
- Pages: 2016-2024
- First Published: 20 March 2021
Open Access
oa
Fibrinolysis vs. primary percutaneous coronary intervention for ST-segment elevation myocardial infarction cardiogenic shock
- Pages: 2025-2035
- First Published: 11 March 2021
Open Access
oa
Health-related quality of life in left ventricular assist device-supported patients
- Pages: 2036-2044
- First Published: 27 March 2021
Open Access
oa
Changes in left ventricular structure and function associated with renal transplantation: a systematic review and meta-analysis
- Pages: 2045-2057
- First Published: 15 March 2021
Open Access
oa
Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction
- Pages: 2058-2069
- First Published: 07 March 2021
Open Access
oa
Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction
- Pages: 2070-2078
- First Published: 10 March 2021
Open Access
oa
Self-care perception and behaviour in patients with heart failure: A qualitative and quantitative study
- Pages: 2079-2088
- First Published: 15 March 2021
Open Access
oa
Diagnostic and prognostic implications of heart failure with preserved ejection fraction scoring systems
- Pages: 2089-2102
- First Published: 11 March 2021
Open Access
oa
Trimethylamine N-oxide and outcomes in patients hospitalized with acute heart failure and preserved ejection fraction
- Pages: 2103-2110
- First Published: 18 March 2021
Open Access
oa
Managing older patients with heart failure calls for a holistic approach
- Pages: 2111-2119
- First Published: 08 April 2021
Open Access
oa
Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT-HFpEF registry
- Pages: 2120-2132
- First Published: 10 March 2021
Open Access
oa
Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables
- Pages: 2133-2143
- First Published: 18 March 2021
Open Access
oa
Recurrent heart failure hospitalizations increase the risk of cardiovascular and all-cause mortality in patients with heart failure in Sweden: a real-world study
- Pages: 2144-2153
- First Published: 09 March 2021
Open Access
oa
Prognostic significance of the HFA-PEFF score in patients with heart failure with preserved ejection fraction
- Pages: 2154-2164
- First Published: 24 March 2021
Open Access
oa
The effect of high-flow arteriovenous fistulas on systemic haemodynamics and brain oxygenation
- Pages: 2165-2171
- First Published: 23 March 2021
Open Access
oa
Influence of renal insufficiency pre-heart transplantation on malignancy risk post-heart transplantation
- Pages: 2172-2182
- First Published: 28 March 2021
Open Access
oa
Exercise training and high-sensitivity cardiac troponin T in patients with heart failure with reduced ejection fraction
- Pages: 2183-2192
- First Published: 23 March 2021
Open Access
oa
Diagnosing heart failure in primary care: individual patient data meta-analysis of two European prospective studies
- Pages: 2193-2201
- First Published: 23 March 2021
Open Access
oa
Palliative key aspects are of importance for symptom relief during the last week of life in patients with heart failure
- Pages: 2202-2209
- First Published: 22 March 2021
Open Access
oa
SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta-analysis
- Pages: 2210-2219
- First Published: 21 March 2021
Open Access
oa
Myocardial work index: a marker of left ventricular contractility in pressure- or volume overload-induced heart failure
- Pages: 2220-2231
- First Published: 23 March 2021
Open Access
oa
Cardiac performance in patients hospitalized with COVID-19: a 6 month follow-up study
- Pages: 2232-2239
- First Published: 27 March 2021
Open Access
oa
Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction
- Pages: 2240-2247
- First Published: 24 March 2021
Open Access
oa
Multiplexed measurement of candidate blood protein biomarkers of heart failure
- Pages: 2248-2258
- First Published: 28 March 2021
Open Access
oa
Epidemiology of cardiogenic shock and cardiac arrest complicating non-ST-segment elevation myocardial infarction: 18-year US study
- Pages: 2259-2269
- First Published: 09 April 2021
Open Access
oa
Association of anaemia and all-cause mortality in patients with ischaemic heart failure varies by renal function status
- Pages: 2270-2281
- First Published: 10 April 2021
Open Access
oa
Association between oral contraceptive use and incident heart failure
- Pages: 2282-2292
- First Published: 09 April 2021
Open Access
oa
Urinary N-terminal pro-brain natriuretic peptide: prognostic value in patients with acute chest pain
- Pages: 2293-2305
- First Published: 06 April 2021
Perspective
Open Access
oa
Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies
- Pages: 2306-2309
- First Published: 02 March 2021
Case Reports
Open Access
oa
Novel dilated cardiomyopathy associated to Calreticulin and Myo7A gene mutation in Usher syndrome
- Pages: 2310-2315
- First Published: 09 April 2021
Open Access
oa
Cardiac rehabilitation with intermittent myocardial ischaemia as a new therapeutic option in refractory angina?
- Pages: 2316-2319
- First Published: 31 March 2021
Short Communications
Open Access
oa
Late gadolinium enhancement characteristics in giant cell myocarditis
- Pages: 2320-2327
- First Published: 02 March 2021
Open Access
oa
Plasma P-selectin is a predictor of mortality in heart failure with preserved ejection fraction
- Pages: 2328-2333
- First Published: 10 March 2021
Open Access
oa
Urinary drug metabolite testing in chronic heart failure patients indicates high levels of adherence with life-prolonging therapies
- Pages: 2334-2337
- First Published: 11 March 2021
Open Access
oa
Outcomes of coronavirus disease-2019 among veterans with pre-existing diagnosis of heart failure
- Pages: 2338-2344
- First Published: 16 March 2021
Open Access
oa
The restricted mean survival time as a replacement for the hazard ratio and the number needed to treat in long-term studies
- Pages: 2345-2348
- First Published: 17 March 2021
Open Access
oa
Outflow graft obstruction after left ventricular assist device implantation: a retrospective, single-centre case series
- Pages: 2349-2353
- First Published: 30 March 2021
Letter to the Editors
Open Access
oa
The other side of the coin: ‘centralization’ against ‘optimization’ in COVID-19 pandemic
- Pages: 2354-2356
- First Published: 08 April 2021
Open Access
oa
In-hospital therapy for worsening heart failure: black box or sweet spot?
- Pages: 2357-2358
- First Published: 18 March 2021
Open Access
oa
Toward reducing thrombus recurrence rate in management of patients with confirmed left ventricular thrombi
- Pages: 2359-2360
- First Published: 21 March 2021